Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus
Abstract
Introduction Pancreatic polypeptide (PP) is a hormone secreted by islet cells of the ventral pancreas. It has been proposed that a blunted PP response to a mixed meal can distinguish diabetes mellitus (DM) secondary to pancreatic disease from other types of DM. We performed a proof of concept study to determine if PP response to a mixed meal discriminates DM secondary to pancreatic cancer (PaCDM) from type 2 DM (T2DM).Methods We studied 18 subjects with new onset DM (PaCDM (n = 9) and T2DM (n = 9); matched for age and gender). Serum PP levels were measured at 0, 30, and 60 min following a mixed meal. Increases in PP levels from baseline were compared using the Wilcoxon test.Results In PaCDM the PP increase following a mixed meal was less than T2DM at 30 min (median 60.0%, IQR, 33.0-119.8 vs. 134.5%, IQR, 117.5-265.9; p = 0.03), but statistically similar at 60 min (median 55.8%, interquartile range (IQR) 23.7-121.5 vs. 100.0%, IQR, 47.7-202.5; p = 0.17). In PaCDM subjects, the PP increase over baseline was smaller in those with a tumor located in the pancreatic head (n = 6) compared to the body/tail (n = 3) at 30 min (41.3% vs. 158.7%, p = 0.02) and at 60 min (37.4% vs. 167.4%,p = 0.04).Conclusions Subjects with PaCDM have a blunted PP response to a mixed meal compared to T2DM. However, the blunted PP response is only observed in those PaC subjects with a tumor located in the head of the pancreas. Confirmation in larger studies may suggest this could be used to aid screening for sporadic PaC.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A small pilot study suggested that pancreatic ductal adenocarcinoma-associated diabetes may be distinguished from type 2 diabetes by a blunted pancreatic polypeptide response to a mixed meal.
“A small pilot study suggested that pancreatic ductal adenocarcinoma-associated diabetes might be distinguished from the more prevalent type 2 diabetes by a blunted pancreatic polypeptide response to a mixed meal.94”
From Early detection of pancreatic cancer (2020) · cites this paper as [94]
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,019 · see citing works
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499 · see citing works
Diagnosis and Classification of diabetes mellitus
Rossi, G. (2014) · Diapedia.org eBooks · doi:10.14496/dia..20 · Cited by 3,212 · see citing works
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.039 · Cited by 621 · see citing works
Self-citationProbability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603 · see citing works
Self-citationProbability of Pancreatic Cancer Following Diabetes: A Population-Based Study
CHARI, S., LEIBSON, C., RABE, K., RANSOM, J., DEANDRADE, M., & PETERSEN, G. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.007 · Cited by 603 · see citing works
Self-citationNew-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Pannala, R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70337-1 · Cited by 562 · see citing works
Self-citationNew insights into pancreatic cancer-induced paraneoplastic diabetes
Sah, R. P., Nagpal, S. J. S., Mukhopadhyay, D., & Chari, S. T. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.49 · Cited by 336 · see citing works
Self-citationDistribution and release of human pancreatic polypeptide.
Adrian, T. E., Bloom, S. R., Bryant, M. G., Polak, J. M., Heitz, P., & Barnes, A. (1976) · Gut · doi:10.1136/gut.17.12.940 · Cited by 313 · see citing works
Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c)
Ewald, N., Kaufmann, C., Raspe, A., Kloer, H. U., Bretzel, R. G., & Hardt, P. D. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2260 · Cited by 307 · see citing works
Pancreatogenic Diabetes: Special Considerations for Management
Cui, Y., & Andersen, D. K. (2011) · Pancreatology · doi:10.1159/000329188 · Cited by 255 · see citing works
Rickels, M. R., Bellin, M., Toledo, F. G. S., Robertson, R. P., Andersen, D. K., Chari, S. T., Brand, R., Frulloni, L., Anderson, M. A., & Whitcomb, D. C. (2013) · Pancreatology · doi:10.1016/j.pan.2013.05.002 · Cited by 249 · see citing works
Self-citation(1993) · PubMed · Cited by 222 · see citing works
Gläser, B., Vinik, A. I., Sive, A. A., & Floyd, J. C. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-6-1094 · Cited by 82 · see citing works
Gingerich, R. L., Lacy, P. E., Chance, R. E., & Johnson, M. G. (1978) · Diabetes · doi:10.2337/diab.27.2.96 · Cited by 75 · see citing works
Rahier, J., Wallon, J., Gepts, W., & Haot, J. (1979) · Cell and Tissue Research · doi:10.1007/bf00234848 · Cited by 69 · see citing works
Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea.
Adrian, T. E., Besterman, H. S., Mallinson, C. N., Garalotis, C., & Bloom, S. R. (1979) · Gut · doi:10.1136/gut.20.2.98 · Cited by 60 · see citing works
Rabiee, A., Galiatsatos, P., Salas-Carrillo, R., et al. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500629 · Cited by 57 · see citing works
Can Plasma Human Pancreatic Polypeptide Be Used To Detect Diseases of the Exocrine Pancreas?
KOCH, M. B., Go, V. L. W., & DiMagno, E. P. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60319-x · Cited by 45 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
Hart, P. A., Bellin, M. D., Andersen, D. K., Bradley, D., Cruz-Monserrate, Z., Forsmark, C. E., Goodarzi, M. O., Habtezion, A., Korc, M., Kudva, Y. C., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30106-6 · Cited by 551 · see citing works
Self-citationDiabetes, pancreatogenic diabetes, and pancreatic cancer
Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes · doi:10.2337/db16-1477 · Cited by 516 · see citing works
Self-citationEarly detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482 · see citing works
Self-citation
- Authors
- Hart, P. A., Baichoo, E., Bi, Y., Hinton, A., Kudva, Y. C., & Chari, S. T.
- Affiliations
- Mayo Clinic (US)
- The Ohio State University (US)
- Corresponding author
- Chari, Suresh T.
- Venue
- Pancreatology
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 15
- Issue
- 2
- Pages
- 162-166
- ISSN
- 1424-3903 (ISSN-L)
- OpenAlex
- W2061555972
- Cited by
- 51
- References
- 19
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 6 · 2019: 5 · 2018: 7 · 2017: 7 · 2016: 2 · 2015: 1
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pancreatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- pancreatic polypeptide, pancreatic head cancer, diabetes mellitus, type 2 diabetes, mixed meal tolerance, islet hormones, tumor location, cancer screening
- MeSH terms
- Aged, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diagnosis, Differential, Eating, Female, Humans, Male, Middle Aged, Pancreas, Pancreatic Neoplasms, Pancreatic Polypeptide, Prospective Studies, Carcinoma, Pancreatic Ductal, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review